Following a trial that stopped early: what next for adjuvant hepatic intra-arterial iodine-131 lipiodol in resectable hepatocellular carcinoma?
Tan
S B
SB
Machin
D
D
Cheung
Y B
YB
Chung
Y F A
YF
Tai
B C
BC
Machin
D
D
D006528:Carcinoma, Hepatocellular / Q000532:radiotherapy* / Q000601:surgery; D016461:Chemoembolization, Therapeutic; D006499:Hepatic Artery; D006801:Humans; D007269:Injections, Intra-Arterial; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D007459:Iodized Oil / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic; D012107:Research Design
D007457:Iodine Radioisotopes; D007459:Iodized Oil